In the announcement from BI, there is a paragraph:
"Boehringer Ingelheim has terminated the agreement with Pharmaxis with 90 days’ notice during which
time Pharmaxis can request return of all existing data and intellectual property."
Does anyone know what that mean to PXS?
- Forums
- ASX - By Stock
- SNT
- Ann: Boehringer Ingelheim discontinues development of BI 1467335
Ann: Boehringer Ingelheim discontinues development of BI 1467335, page-17
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $28.65M |
Open | High | Low | Value | Volume |
2.2¢ | 2.5¢ | 2.2¢ | $12.04K | 509.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 82668 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 82668 | 0.023 |
2 | 338839 | 0.022 |
5 | 1736248 | 0.021 |
11 | 2801008 | 0.020 |
2 | 999988 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 100000 | 1 |
0.025 | 100000 | 1 |
0.026 | 50000 | 1 |
0.027 | 200000 | 1 |
0.028 | 500000 | 1 |
Last trade - 15.57pm 28/06/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online